The California-Mexico-Puerto Rico (CAMPO) Consortium (part of the National Cancer Institute-funded US-Latin American-Caribbean HIV/HPV-Cancer Prevention Clinical Trials Network [ULACNet, NCI grant # U54CA242646) conducts clinical trials (CTs) to prevent HPV-related cancers among people living with HIV (PLWH) in Mexico and Puerto Rico (PR). In PR, the CAMPO study is led by Dr. Ana Patricia Ortiz, an Investigator at the Division of Cancer Control and Population Sciences of the University of Puerto Rico Comprehensive Cancer Center. Different recruitment strategies are being implemented to enroll 1,400 PLWH for ULACNet-101, the first of three CTs under the CAMPO Consortium, including on-site promotion in HIV clinics by research staff and healthcare provider referrals.
- An update about the CAMPO study can be accessed through the following website or by scanning the QR code.
- To establish an agreement to promote the CAMPO study within your clinic or obtain more information to collaborate with CAMPO, please contact Mariela Bournigal ( 787-772-8300 ext. 1102) or Sandra García (787-772-8300 ext. 5270).
- If you live with HIV and want to participate in the CAMPO study, please fill out a contact information form at the following secure website . A CAMPO staff member will call you to give you more information about CAMPO and determine your eligibility for the study.
